Intraocular pressure, safety and quality of life in glaucoma patients switching to latanoprost from adjunctive and monotherapy treatments

被引：0
|
作者：
Wünsch, S
Haverkamp, F
Sand, G
Fuchs, M
Stewart, WC
机构：
[1] Pharmacia GmbH, Erlangen, Germany
[2] Univ Bonn, Childrens Hosp, D-5300 Bonn, Germany
[3] Eye Clin, Ingoldstadt, Germany
[4] Pharmaceut Res Cooperat, Charleston, SC USA
[5] Univ S Carolina, Sch Med, Carolina Eye Inst, Columbia, SC USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2003年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
793
引用
收藏
页码：U229 / U229
页数：1
相关论文
共 50 条
  • [41] A comparison of the effect of timolol, latanoprost, and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi, N
    Rossetti, L
    Invernizzi, T
    Bottoli, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S186 - S186
  • [42] Comparison study of the intraocular-pressure reduction efficacy and safety between bimatoprost and latanoprost-timolol-fixed combination in Japanese open-angle glaucoma patients who switched from latanoprost
    Maruyama, Yuko
    Ikeda, Yoko
    Mori, Kazuhiko
    Ueno, Morio
    Yoshikawa, Haruna
    Kinoshita, Shigeru
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [43] Efficacy of locally produced Latanoprost in the control of intraocular pressure in patients with primary open-angle glaucoma
    Pir Salim Mahar
    Nadeem H. Butt
    Syed Imtiaz Ali
    International Ophthalmology, 2018, 38 : 2593 - 2597
  • [44] DIURNAL INTRAOCULAR PRESSURE RE-DUCTION WITH LATANOPROST 0,005% COMPARED TO TIMOLOL MALEATE 0,5% AS MONOTHERAPY IN PATIENTS WITH EXFOLIATION GLAUCOMA
    A.G.P.Konstas
    N.Mylopoulos
    C.H.Karabatsas
    V.P.Kozobolis
    S.Diafas
    P.Papapanos
    W.C.Stewart
    国际眼科杂志, 2003, (01) : 26 - 27
  • [45] Rilmenidine: Safety and efficacy on intraocular pressure in healthy volunteers and glaucoma patients
    Nordmann, JP
    Elena, PP
    Mandrino, P
    Castagne, I
    Vilain, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 2600 - 2600
  • [46] 24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost
    Nakamura, Yoshimi
    Ishikawa, Shusaku
    Nakamura, Yuko
    Sakai, Hiroshi
    Henzan, Ichiko
    Sawaguchi, Shoichi
    CLINICAL OPHTHALMOLOGY, 2009, 3 : 395 - 400
  • [47] Efficacy of locally produced Latanoprost in the control of intraocular pressure in patients with primary open-angle glaucoma
    Mahar, Pir Salim
    Butt, Nadeem H.
    Ali, Syed Imtiaz
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (06) : 2593 - 2597
  • [48] Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost
    Tamer, Cengaver
    Oksuz, Huseyin
    OPHTHALMIC RESEARCH, 2007, 39 (01) : 24 - 31
  • [49] Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma
    Tamada, Y
    Taniguchi, T
    Murase, H
    Yamamoto, T
    Kitazawa, Y
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2001, 17 (01) : 19 - 25
  • [50] Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial
    Mansouri, K.
    Orguel, S.
    Mermoud, A.
    Haefliger, I.
    Flammer, J.
    Ravinet, E.
    Shaarawy, T.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (03) : 332 - 336
12345